Medicare Enrolled
Dr. Aaron Denson, M.D.
Internal Medicine · Brooksville, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Denson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Denson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Denson
Dr. Aaron Denson is an internal medicine specialist in Brooksville, FL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Denson performed 92,596 Medicare services across 2,780 unique beneficiaries.
Between the years covered by Open Payments, Dr. Denson received a total of $38,264 from 97 pharmaceutical and/or device companies across 1176 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Denson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 0% volume in FL
$38,264 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 126695 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗92,596
Medicare services
Top 0% in FL for internal medicine
2,780
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,123 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 14,790 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 13,880 | $6 | $25 |
| Denosumab injection (Prolia/Xgeva) | 13,260 | $18 | $68 |
| Anti-nausea injection (fosaprepitant) | 10,500 | $0 | $1 |
| Iron infusion (Monoferric) | 9,900 | $17 | $69 |
| Epoetin alfa injection (Retacrit) for anemia | 7,461 | $6 | $24 |
| Injection, granisetron hydrochloride, 100 mcg | 3,967 | $0 | $1 |
| Dexamethasone injection (steroid) | 3,288 | $0 | $0 |
| Complete blood count (CBC) with differential | 1,929 | $8 | $23 |
| Contrast dye for imaging (iodine-based) | 1,900 | $0 | $1 |
| Injection, leucovorin calcium, per 50 mg | 1,537 | $3 | $11 |
| Blood draw (venipuncture) | 1,230 | $8 | $24 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,110 | $1 | $3 |
| Drug injection, under skin or into muscle | 916 | $10 | $42 |
| Injection, fluorouracil, 500 mg | 836 | $2 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 772 | $22 | $85 |
| Comprehensive metabolic blood panel | 701 | $10 | $32 |
| Administration of chemotherapy into vein, 1 hour or less | 686 | $97 | $383 |
| Injection of additional new drug or substance into vein | 602 | $12 | $45 |
| Office visit, established patient (20-29 min) | 504 | $64 | $269 |
| Ferritin level test (iron stores) | 351 | $13 | $41 |
| Office visit, established patient (30-39 min) | 294 | $90 | $383 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 272 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 198 | $46 | $187 |
| Administration of additional new drug or substance into vein, 1 hour or less | 160 | $48 | $189 |
| Injection, diphenhydramine hcl, up to 50 mg | 152 | $1 | $3 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 148 | $54 | $212 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 125 | $1,181 | $4,598 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 117 | $401 | $1,533 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 115 | $20 | $62 |
| Administration of chemotherapy into vein, each additional hour | 105 | $21 | $83 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 91 | $125 | $159 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 74 | $25 | $99 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 72 | $15 | $60 |
| Infusion, normal saline solution , 1000 cc | 66 | $2 | $8 |
| Injection of drug or substance into vein | 64 | $28 | $108 |
| Urinalysis, manual | 63 | $3 | $10 |
| PSA test (prostate cancer screening) | 63 | $18 | $55 |
| Infusion into a vein for hydration, each additional hour | 52 | $10 | $37 |
| Unclassified drugs | 50 | $1 | $9 |
| Carcinoembryonic antigen (cea) protein level | 43 | $19 | $57 |
| Infusion into a vein for hydration, 31-60 minutes | 40 | $25 | $95 |
| Folic acid level, rbc | 38 | $17 | $53 |
| New patient office visit, complex (60-74 min) | 32 | $173 | $662 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 26 | $16 | $68 |
| New patient office visit (45-59 min) | 16 | $122 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
28.1% high complexity
65.8% medium
6.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$38,264
Total received (2018-2024)
Avg $5,466/year across 7 years
Top 2% in FL for internal medicine
97
Companies
1,176
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,525 (53.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,493 (40.5%)
Other
Charitable contributions, space rental, and other categories
$1,526 (4.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$720 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$10,468
2023
$6,435
2022
$7,719
2021
$10,595
2020
$1,978
2019
$789
2018
$280
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$4,427
PFIZER INC.
$3,874
Novartis Pharmaceuticals Corporation
$3,660
EMD Serono, Inc.
$3,041
E.R. Squibb & Sons, L.L.C.
$2,384
Celgene Corporation
$1,630
JAZZ PHARMACEUTICALS INC.
$1,539
Astellas Pharma US Inc
$1,385
Seagen Inc.
$1,326
Lilly USA, LLC
$1,107
Gilead Sciences, Inc.
$843
Genentech USA, Inc.
$789
Janssen Biotech, Inc.
$662
Merck Sharp & Dohme LLC
$641
GENZYME CORPORATION
$610
Eisai Inc.
$602
Daiichi Sankyo Inc.
$565
Bayer Healthcare Pharmaceuticals Inc.
$559
Merck Sharp & Dohme Corporation
$460
Kite Pharma, Inc.
$432
Amgen Inc.
$404
Incyte Corporation
$338
US Oncology Corporate, Inc.
$318
Pharmacyclics LLC, An AbbVie Company
$308
GlaxoSmithKline, LLC.
$276
Bayer HealthCare Pharmaceuticals Inc.
$275
Karyopharm Therapeutics Inc.
$263
Rigel Pharmaceuticals, Inc.
$263
Boehringer Ingelheim Pharmaceuticals, Inc.
$262
Seattle Genetics, Inc.
$248
Regeneron Healthcare Solutions, Inc.
$220
Ipsen Biopharmaceuticals, Inc
$201
Novocure GmbH
$200
Tempus AI, Inc
$193
Stemline Therapeutics Inc.
$192
AbbVie Inc.
$187
EISAI INC.
$186
Octapharma USA, Inc.
$175
Athenex Pharmaceutical Division, LLC
$175
Takeda Pharmaceuticals U.S.A., Inc.
$174
ARRAY BIOPHARMA INC
$153
Pharmacosmos Therapeutics Inc.
$133
Ethicon Inc.
$132
G1 Therapeutics, Inc.
$120
Celltrion USA Inc.
$114
Mirati Therapeutics, Inc.
$103
NOVARTIS PHARMACEUTICALS CORPORATION
$100
SEAGEN INC.
$99
SERVIER PHARMACEUTICALS LLC
$92
ABBVIE INC.
$91
SUN PHARMACEUTICAL INDUSTRIES INC.
$91
PUMA BIOTECHNOLOGY, INC.
$90
BeiGene USA, Inc.
$78
SOBI, INC
$72
Jazz Pharmaceuticals Inc.
$71
Agios Pharmaceuticals, Inc.
$71
Sumitomo Pharma America, Inc.
$60
Myriad Genetic Laboratories, Inc.
$60
Dova Pharmaceuticals
$57
AVEO Pharmaceuticals, Inc.
$55
AbbVie, Inc.
$54
Fennec Pharmaceuticals, Inc.
$52
Foundation Medicine, Inc.
$52
Pharmacyclics LLC, an AbbVie Company
$48
Servier Pharmaceuticals LLC
$47
SANOFI-AVENTIS U.S. LLC
$43
Aveo Pharmaceuticals, Inc.
$42
Deciphera Pharmaceuticals Inc.
$39
Verity Pharmaceuticals Inc.
$39
Epizyme, Inc.,
$39
Myovant Sciences Inc.
$39
Sun Pharmaceutical Industries Inc.
$37
Alexion Pharmaceuticals, Inc.
$30
Heron Therapeutics, Inc.
$29
Dendreon Pharmaceuticals LLC
$27
SpringWorks Therapeutics, Inc.
$26
Legend Biotech USA Inc.
$25
Immunomedics, Inc.
$24
PharmaEssentia USA Corporation
$23
Telix Pharmaceuticals
$22
Sirtex Medical Inc
$22
Puma Biotechnology, Inc.
$22
MorphoSys, US Inc.
$20
Blueprint Medicines Corporation
$20
Genmab U.S., Inc.
$18
ADC Therapeutics America, Inc.
$18
Amneal Pharmaceuticals LLC
$17
GE HEALTHCARE
$17
Mylan Institutional Inc.
$17
TAIHO ONCOLOGY, INC.
$16
Advanced Accelerator Applications
$16
Helsinn Therapeutics (U.S.), Inc.
$16
Partner Therapeutics, Inc.
$15
Kyowa Kirin, Inc.
$15
Organon LLC
$14
Clovis Oncology, Inc.
$13
Accord Healthcare, Inc.
$12
Top 3 companies account for 31.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AVASTIN · AYVAKIT · Activase · Alecensa · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CALQUENCE · CAMCEVI · CINVANTI · COSELA · CYRAMZA · Cinvanti · Columvi · Cresemba · DARZALEX · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · ENJAYMO · ERLEADA · EVENITY · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Gazyva · Halaven · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · Monarch Platform · NERLYNX · NINLARO · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONIVYDE · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Ogivri · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tepmetko · Tibsovo · Trelstar · Trodelvy · ULTOMIRIS · VEGZELMA · VENCLEXTA · VERZENIO · VYXEOS · Vanflyta · Vectibix · Venclexta · Vitrakvi · XALKORI · XOSPATA · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for internal medicine in FL.
Equivalent to $41 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
308
Per 100K population
152.8
County median income
$63,193
Nearest hospital
HCA FLORIDA OAK HILL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Denson is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with low-engagement industry engagement in the top 2% of FL peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Denson experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Denson performed 14,790 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Denson receive payments from pharmaceutical companies?
Yes. Dr. Denson received a total of $38,264 from 97 companies across 1,176 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Denson's costs compare to other internal medicine physicians in Brooksville?
Dr. Denson's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Denson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Brooksville
Browse internal medicine physicians in Brooksville ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in FL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in FL
Which FL internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology